Analysis of the in vitro activity of trovafloxacin (CP-99,219) against Bacteroides species

被引：7

作者：

Snydman, DR

McDermott, L

机构：

[1] TUFTS UNIV NEW ENGLAND MED CTR,DEPT MED,BOSTON,MA 02111

[2] TUFTS UNIV,SCH MED,BOSTON,MA 02111

来源：

INFECTIOUS DISEASES IN CLINICAL PRACTICE | 1996年 / 5卷

关键词：

D O I：

10.1097/00019048-199606001-00003

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

[No abstract available]

引用

页码：S96 / S100

页数：5

共 50 条

[1] Bactericidal activity of trovafloxacin (CP-99,219)
Morrissey, I
[J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1996, 38 (06) : 1061 - 1066
[2] Intracellular activity of trovafloxacin (CP-99,219) against Enterococcus faecium
HerreraInsua, I
JacquesPalaz, K
Murray, BE
Rakita, RM
[J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1997, 39 (04) : 552 - 553
[3] In vitro activity of trovafloxacin (CP-99,219), sparfloxacin, ciprofloxacin, and fleroxacin against respiratory pathogens
Crokaert, F
Aoun, M
Duchateau, V
Grenier, P
Vandermies, A
Klastersky, J
[J]. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1996, 15 (08) : 696 - 698
[4] Pharmacokinetics and penetration into inflammatory fluid of trovafloxacin (CP-99,219)
Wise, R
Mortiboy, D
Child, J
Andrews, JM
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (01) : 47 - 49
[5] Comparative in-vitro activity of the new fluoroquinolone trovafloxacin (CP-99,219) against Gram-positive cocci
Coque, TM
Singh, KV
Murray, BE
[J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1996, 37 (05) : 1011 - 1016
[6] IN-VITRO ACTIVITY OF THE NEW FLUOROQUINOLONE CP-99,219
NEU, HC
CHIN, NX
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1994, 38 (11) : 2615 - 2622
[7] Evaluation of in vitro activity of a new fluoroquinolone trovafloxacin (cp-99,219) compared with other anti-anaerobic antimicrobials against members of the Bacteroides fragilis group
Borobio, MV
Suarez, AI
Ramirez, E
Perea, EJ
[J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 1997, 8 (04) : 249 - 252
[8] Activity of the new fluoroquinolone trovafloxacin (CP-99,219) against DNA gyrase and topoisomerase IV mutants of Streptococcus pneumoniae selected in vitro
Gootz, TD
Zaniewski, R
Haskell, S
Schmieder, B
Tankovic, J
Girard, D
Courvalin, P
Polzer, RJ
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (12) : 2691 - 2697
[9] Pharmacokinetics of trovafloxacin (CP-99,219), a new quinolone, in rats, dogs, and monkeys
Teng, RL
Girard, D
Gootz, TD
Foulds, G
Liston, TE
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (03) : 561 - 566
[10] In vitro activity of trovafloxacin (CP 99,219), a new fluoroquinolone against hospital isolates
Ling, TKW
Liu, EYM
Cheng, AFB
[J]. CHEMOTHERAPY, 1999, 45 (01) : 22 - 27

← 1 2 3 4 5 →